Clinical Trial Update: IL-13 Blockade and Airway Autoimmunity in Asthma

View source ↗

Summary

This update reports the completion of a clinical trial evaluating blockade of interleukin-13 in airway autoimmunity associated with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IL-13 blockade agent (anti-IL-13 monoclonal antibody)

Snippet

Sponsor: McMaster University | Conditions: Airway Auto Immunity in Asthma | Status: COMPLETED